Error: Could not add to watchlist. X
+ Watchlist

Alnylam Pharmaceuticals Inc

ALNY:US
NASDAQ GS
85.21
USD
1.25
1.49%
As of 8:10 PM EDT 6/23/2017
Open
83.96
Day Range
82.13 - 85.33
Volume
773,700
Previous Close
83.96
52Wk Range
31.38 - 86.92
1 Yr Return
56.90%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
83.96
Day Range
82.13 - 85.33
Volume
773,700
Previous Close
83.96
52Wk Range
31.38 - 86.92
1 Yr Return
56.90%
YTD Return
127.59%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.85
Market Cap (b USD)
7.796
Shares Outstanding (m)
91.488
Price/Sales (TTM)
124.43
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company. The Company discovers and develops drug and medicines for the treatment of human disease. Alnylam Pharmaceuticals serves health care sectors in the United States and the United Kingdom.
Address
300 3rd Street
3rd Floor
Cambridge, MA 02142
United States
Phone
1-617-551-8200
  • John M Maraganore
    Chief Executive Officer
  • Barry E Greene
    President
  • Pushkal Garg
    Chief Medical Officer
  • Yvonne Greenstreet
    Exec VP/COO
  • Manmeet S Soni
    Senior VP/CFO
Show More